[
    [
        {
            "time": "2019-07-18",
            "original_text": "Novartis AG (NVS) Q2 Earnings Call Transcript Pharma Giant Flirts With Record High As Copycat Drugs Gain Steam Novartis AG (NVS) Q2 Earnings Call Transcript",
            "features": {
                "keywords": [
                    "Novartis",
                    "Q2 Earnings",
                    "Pharma Giant",
                    "Record High",
                    "Copycat Drugs"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Novartis AG (NVS) Q2 Earnings Call Transcript Pharma Giant Flirts With Record High As Copycat Drugs Gain Steam Novartis AG (NVS) Q2 Earnings Call Transcript",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-07-18",
            "original_text": "Is a Beat in Store for Glaxo (GSK) This Earnings Season? Novartis (NVS) Beats on Q2 Earnings & Sales, Raises Guidance",
            "features": {
                "keywords": [
                    "Glaxo",
                    "Earnings Season",
                    "Novartis",
                    "Beats",
                    "Q2 Earnings",
                    "Raises Guidance"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Is a Beat in Store for Glaxo (GSK) This Earnings Season? Novartis (NVS) Beats on Q2 Earnings & Sales, Raises Guidance",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-07-18",
            "original_text": "Where Will Tilray Be in 5 Years? [video]Novartis Up on Financial Results and Potential Resolution of Kickback Case",
            "features": {
                "keywords": [
                    "Tilray",
                    "Novartis",
                    "Financial Results",
                    "Kickback Case"
                ],
                "sentiment_score": 0.65,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Where Will Tilray Be in 5 Years? [video]Novartis Up on Financial Results and Potential Resolution of Kickback Case",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-07-18",
            "original_text": "Stocks Stumble As Netflix Dives; Dow Jones Stock IBM Breaks Out, Apple Upgraded Health Care Sector Update for 07/18/2019: CODX, IDXG, NVS, JNJ, PFE, ABT, MRK, AMGN",
            "features": {
                "keywords": [
                    "Stocks",
                    "Netflix",
                    "Dow Jones",
                    "IBM",
                    "Apple",
                    "Health Care Sector",
                    "NVS",
                    "JNJ",
                    "PFE"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "technology",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Stocks Stumble As Netflix Dives; Dow Jones Stock IBM Breaks Out, Apple Upgraded Health Care Sector Update for 07/18/2019: CODX, IDXG, NVS, JNJ, PFE, ABT, MRK, AMGN",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-07-18",
            "original_text": "Novartis Earnings Top; Swiss Drug Giant Soars Pre-Market Most Active for Jul 18, 2019 : NYMT, FDC, ERIC, NFLX, AMD, FISV, NOK, TVIX, ACB, NVS, TEVA, TOT",
            "features": {
                "keywords": [
                    "Novartis",
                    "Earnings Top",
                    "Swiss Drug Giant",
                    "Pre-Market Most Active"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Novartis Earnings Top; Swiss Drug Giant Soars Pre-Market Most Active for Jul 18, 2019 : NYMT, FDC, ERIC, NFLX, AMD, FISV, NOK, TVIX, ACB, NVS, TEVA, TOT",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-07-18",
            "original_text": "Stock Futures Dip As Netflix Drags On Nasdaq; eBay, Novartis Spike Novartis raises full-year targets, aims to settle U.S. lawsuit",
            "features": {
                "keywords": [
                    "Stock Futures",
                    "Netflix",
                    "Nasdaq",
                    "eBay",
                    "Novartis",
                    "Full-Year Targets",
                    "U.S. Lawsuit"
                ],
                "sentiment_score": 0.4,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "technology",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Stock Futures Dip As Netflix Drags On Nasdaq; eBay, Novartis Spike Novartis raises full-year targets, aims to settle U.S. lawsuit",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-07-18",
            "original_text": "Novartis’s Brightened Outlook Pushes Shares to All-Time High Novartis raises 2019 guidance, helped by Sandoz generics unit",
            "features": {
                "keywords": [
                    "Novartis",
                    "Brightened Outlook",
                    "All-Time High",
                    "2019 Guidance",
                    "Sandoz Generics Unit"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Novartis’s Brightened Outlook Pushes Shares to All-Time High Novartis raises 2019 guidance, helped by Sandoz generics unit",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 10,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-07-18",
            "original_text": "StockBeat: A Sea of Red as Earnings Live Down to Expectations",
            "features": {
                "keywords": [
                    "StockBeat",
                    "Earnings",
                    "Live Down",
                    "Expectations"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "general market"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 5,
                "Sentiment": 3,
                "Importance": 4,
                "Impact": 3,
                "Duration": 2,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        }
    ]
]